Elsevier,
Current Developments in Nutrition, Volume 8, July 2024
The article concludes that advancing sustainable diet research and policy in the United States requires regular federal updates and integration of the Food Commodity Intake Database within the national nutrition data system. The FCIDs unique ability to link dietary data to multiple sustainability domains makes it indispensable for comprehensive analysis. Without timely updates and coordinated efforts, research will remain limited and policy decisions inadequately informed, hindering progress towards healthier, more sustainable food systems. Increased federal investment and interagency collaboration are necessary to build robust data infrastructure supporting sustainable diet initiatives and improved public health outcomes.
Elsevier,
iScience, Volume 27, 19 July 2024
This study applied sodium lignosulfonate (SL) and ZnO nanoparticles (ZnO NPs) as functional filler and structure components, respectively, on the cellulose nanofibers (CNFs)-based films, which shows promise towards improving shelf life in food packaging.
Elsevier,
American Journal of Clinical Nutrition, Volume 120, July 2024
The study reveals that achieving both environmental sustainability and nutrient adequacy in the diets of children and adolescents is challenging, as diets richer in nutrients tend to have a greater ecological footprint. While there is some evidence of recent improvements in diet-related environmental indicators, substantial capacity for change remains. The article calls for targeted interventions and population-specific dietary guidelines that consider both health and environmental impacts, particularly for vulnerable youth populations. More comprehensive research is needed to develop sustainable dietary strategies that do not compromise essential nutrition for growing children and adolescents.
Elsevier,
Journal of Nutrition, Health and Aging, Volume 28, July 2024
The study evaluated the effects of a personalized dietary strategy based on individualized foods and digital tools on the overall health status and quality of life in older adults with overweight or obesity. The precision approach demonstrated significantly better outcomes compared to standard recommendations, including improvements in body weight, body composition, metabolic health, and quality of life.
Elsevier,
Neurochemistry International, Volume 177, July 2024
This review provides a comprehensive overview of both conventional and novel therapeutic strategies for Alzheimer's disease (AD), highlighting traditional Acetylcholinesterase (AChE) inhibition and emerging approaches such as Butyrylcholinesterase (BChE) inhibition, Tau Protein inhibitors, and COX-2 inhibition, while also exploring the roles of endocannabinoids, cholesterol-lowering drugs, and microRNA, alongside novel research tools and current clinical trials, to offer a consolidated resource for advancing AD treatment and research.
Elsevier,
Journal of Nutrition, Volume 154, July 2024
This study aimed to examine relationships among eating frequency, timing and time window, and cognitive performance and novel Alzheimer disease (AD) biomarkers in cognitively healthy and mildly cognitively impaired middle-aged and older adults. It concluded that an eating pattern characterized by less frequent eating and/or by earlier times is present in individuals with worse cognitive performance. The results shed light on the relevance of temporal eating patterns as potential early markers of behavioral or metabolic changes related to AD pathology.
Elsevier,
Neuroscience Research, Volume 204, July 2024
This study found that Alzheimer’s disease neuropathological change (ADNC) is associated with gene expression changes that may impair cholesterol biosynthesis in neurones but not astrocytes, whilst levels of cortical cholesterol show a weak relationship to dementia status.
Elsevier,
Acta Pharmaceutica Sinica B, Volume 14, July 2024
The study discusses the latest developments in Alzheimer’s disease treatment, with a focus on monoclonal antibodies and aptamers. It covers the current state of therapies, recent drug approvals, and future perspectives on immunotherapeutic strategies.

